Download PDF
Planta Med 2018; 84(12/13): 834-838
DOI: 10.1055/a-0631-3876
Perspectives
Georg Thieme Verlag KG Stuttgart · New York

Ethnobotany and Medicinal Plant Biotechnology: From Tradition to Modern Aspects of Drug Development[*]

Oliver Kayser
TU Dortmund University, Biochemical and Chemical Engineering, Technical Biochemistry, Dortmund, Germany
› Author Affiliations
Further Information

Publication History

received 28 February 2018
revised 09 May 2018

accepted 10 May 2018

Publication Date:
24 May 2018 (online)

   Permissions and Reprints

Abstract

Secondary natural products from plants are important drug leads for the development of new drug candidates for rational clinical therapy and exhibit a variety of biological activities in experimental pharmacology and serve as structural template in medicinal chemistry. The exploration of plants and discovery of natural compounds based on ethnopharmacology in combination with high sophisticated analytics is still today an important drug discovery to characterize and validate potential leads. Due to structural complexity, low abundance in biological material, and high costs in chemical synthesis, alternative ways in production like plant cell cultures, heterologous biosynthesis, and synthetic biotechnology are applied. The basis for any biotechnological process is deep knowledge in genetic regulation of pathways and protein expression with regard to todays “omics” technologies. The high number genetic techniques allowed the implementation of combinatorial biosynthesis and wide genome sequencing. Consequently, genetics allowed functional expression of biosynthetic cascades from plants and to reconstitute low-performing pathways in more productive heterologous microorganisms. Thus, de novo biosynthesis in heterologous hosts requires fundamental understanding of pathway reconstruction and multitude of genes in a foreign organism. Here, actual concepts and strategies are discussed for pathway reconstruction and genome sequencing techniques cloning tools to bridge the gap between ethnopharmaceutical drug discovery to industrial biotechnology.

Key words

ethnobotany - pharmacognosy - phytochemistry - systems biology - metabolic engineering - bioengineering - synthetic biology - microbial cell factories

* Dedicated to Professor Dr. Robert Verpoorte in recognition of his outstanding contribution to natural products research.


 

  • References

  • 1 Gurib-Fakim A. Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol Aspects Med 2006; 27: 1-93
    CrossrefPubMedGoogle Scholar
  • 2 Heinrich M, Heneka B, Rimpler H, Ankli A, Sticher O, Kostiza T. Spasmolytic and antidiarrhoeal properties of the Yucatec Mayan medicinal plant Casimiroa tetrameria . J Pharm Pharmacol 2005; 57: 1081-1085
    CrossrefPubMedGoogle Scholar
  • 3 World Health Organization (WHO). WHO Traditional Medicine Strategy: 2014 – 2023. Geneva, Switzerland: WHO Press; 2013
    Google Scholar
  • 4 Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 2016; 79: 629-661
    CrossrefPubMedGoogle Scholar
  • 5 Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 2013; 1830: 3670-3695
    CrossrefPubMedGoogle Scholar
  • 6 Harvey AL. Natural products in drug discovery. Drug Discov Today 2008; 13: 894-901
    CrossrefPubMedGoogle Scholar
  • 7 Shen B. A new golden age of natural products drug discovery. Cell 2015; 163: 1297-1300
    CrossrefPubMedGoogle Scholar
  • 8 Li JWH, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier?. Science 2009; 325: 161-165
    CrossrefPubMedGoogle Scholar
  • 9 Clardy J, Fischbach MA, Walsh CT. New antibiotics from bacterial natural products. Nat Biotechnol 2006; 24: 1541-1550
    CrossrefPubMedGoogle Scholar
  • 10 Fedoroff NV. Prehistoric GM corn. Science 2003; 302: 1158-1159
    CrossrefPubMedGoogle Scholar
  • 11 Acquaah G. Principles of Plant Genetics and Breeding. Malden, MA: Blackwell Publishing; 2007: 3-15
    Google Scholar
  • 12 Mendel G. Versuche über Pflanzen-Hybriden. Sch Publ 1866; 1865: 3-47
    PubMedGoogle Scholar
  • 13 Heinrich M. Ethnopharmacy and natural product research – multidisciplinary opportunities for research in the metabolomic age. Phytochem Lett 2008; 1: 1-5
    CrossrefPubMedGoogle Scholar
  • 14 Nielsen J, Keasling JD. Engineering cellular metabolism. Cell 2016; 164: 1185-1197
    CrossrefPubMedGoogle Scholar
  • 15 Hawkins KM, Smolke CD. Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae . Nat Chem Biol 2008; 4: 564-573
    CrossrefPubMedGoogle Scholar
  • 16 Hansen EH, Møller BL, Kock GR, Bünner CM, Kristensen C, Jensen OR, Okkels FT, Olsen CE, Motawia MS, Hansen J. De novo biosynthesis of Vanillin in fission yeast (Schizosaccharomyces pombe) and bakerʼs yeast (Saccharomyces cerevisiae). Appl Environ Microbiol 2009; 75: 2765-2774
    CrossrefPubMedGoogle Scholar
  • 17 Wolfson W. Evolva breeds small molecule drugs au naturel. Chem Biol 2009; 16: 577-578
    CrossrefPubMedGoogle Scholar
  • 18 Degenhardt F, Stehle F, Kayser O. The Biosynthesis of Cannabinoids. In: Preedy VR. ed. Handbook of Cannabis and related Pathologies. Cambridge, MA: Academic Press; 2017: 13-23
    CrossrefGoogle Scholar
  • 19 Matasci N, Hung LH, Yan Z, Carpenter EJ, Wickett NJ, Mirarab S, Nguyen N, Warnow T, Ayyampalayam S, Barker M, Burleigh JG, Gitzendanner MA, Wafula E, Der JP, dePamphilis CW, Roure B, Philippe H, Ruhfel BR, Miles NW, Graham SW, Mathews S, Surek B, Melkonian M, Soltis DE, Soltis PS, Rothfels C, Pokorny L, Shaw JA, DeGironimo L, Stevenson DW, Villarreal JC, Chen T, Kutchan TM, Rolf M, Baucom RS, Deyholos MK, Samudrala R, Tian Z, Wu X, Sun X, Zhang Y, Wang J, Leebens-Mack J, Wong GKS. Data access for the 1, 000 Plants (1KP) project. Gigascience 2014; 3: 17
    CrossrefPubMedGoogle Scholar
  • 20 Chen S, Xiang L, Guo X, Li Q. An introduction to the medicinal plant genome project. Front Med 2011; 5: 178-184
    CrossrefPubMedGoogle Scholar
  • 21 Ulrich-Merzenich G, Panek D, Zeitler H, Wagner H, Vetter H. New perspectives for synergy research with the ‘OMIC’-technologies. Phytomedicine 2009; 16: 495-508
    CrossrefPubMedGoogle Scholar
  • 22 Verpoorte R, Choi YH, Kim HK. Metabolomics: will it stay?. Phytochem Anal 2010; 21: 2-3
    CrossrefPubMedGoogle Scholar
  • 23 Verpoorte R, Choi YH, Kim HK. Ethnopharmacology and systems biology: a perfect holistic match. J Ethnopharmacol 2005; 100: 53-56
    CrossrefPubMedGoogle Scholar
  • 24 Li JJ. History of Drug Discovery. In: Li JJ, Corey EJ. eds. Drug Discovery: Practices, Processes, and Perspectives. Hoboken, NJ: John Wiley & Sons; 2013: 1-42
    CrossrefGoogle Scholar
  • 25 Ullrich SF, Hagels H, Kayser O. Scopolamine: a journey from the field to clinics. Phytochem Rev 2017; 16: 333-353 doi:10.1007/s11101-016-9477-x
    CrossrefPubMedGoogle Scholar
  • 26 Kreis W, Baron D, Stoll G. Biotechnologie der Arzneistoffe. Stuttgart, Germany: Deutscher Apotheker Verlag; 2001
    Google Scholar
  • 27 Wink M, Alfermann AW, Franke R, Wetterauer B, Distl M, Windhövel J, Krohn O, Fuss E, Garden H, Mohagheghzadeh A, Wildi E, Ripplinger P. Sustainable bioproduction of phytochemicals by plant in vitro cultures: anticancer agents. Plant Genet Resour Charact Util 2005; 3: 90-100
    CrossrefPubMedGoogle Scholar
  • 28 Tabata M, Fujita Y. Production of Shikonin in Plant Cell Cultures. In: Zaitlin M. ed. Biotechnology in Plant Science. Cambridge, MA: Academic Press; 1985: 207-218
    CrossrefGoogle Scholar
  • 29 Facchini PJ, Bohlmann J, Covello PS, De Luca V, Mahadevan R, Page JE, Ro DK, Sensen CW, Storms R, Martin VJJ. Synthetic biosystems for the production of high-value plant metabolites. Trends Biotechnol 2012; 30: 127-131
    CrossrefPubMedGoogle Scholar
  • 30 Howat S, Park B, Oh IS, Jin YW, Lee EK, Loake GJ. Paclitaxel: biosynthesis, production and future prospects. N Biotechnol 2014; 31: 242-245
    CrossrefPubMedGoogle Scholar
  • 31 Renneberg R. Biotech history: Yew trees, paclitaxel synthesis and fungi. Biotechnol J 2007; 2: 1207-1209
    CrossrefPubMedGoogle Scholar
  • 32 Cusido RM, Onrubia M, Sabater-Jara AB, Moyano E, Bonfill M, Goossens A, Angeles Pedreño M, Palazon J. A rational approach to improving the biotechnological production of taxanes in plant cell cultures of Taxus spp. Biotechnol Adv 2014; 32: 1157-1167
    CrossrefPubMedGoogle Scholar
  • 33 Muñoz-Torrero D, Cortés A, Mariño EL, Cusidó RM, Vidal H, Gallego A, Abdoli M, Palazón J. 6. Biotechnological production of taxanes: a molecular approach. Transw Res Netw 2013; 37661: 91-107
    PubMedGoogle Scholar
  • 34 Onrubia M, Cusidó RM, Ramirez K, Hernández-Vázquez L, Moyano E, Bonfill M, Palazon J. Bioprocessing of plant in vitro systems for the mass production of pharmaceutically important metabolites: paclitaxel and its derivatives. Curr Med Chem 2013; 20: 880-891
    PubMedGoogle Scholar
  • 35 Khosroushahi AY, Valizadeh M, Ghasempour A, Khosrowshahli M, Naghdibadi H, Dadpour MR, Omidi Y. Improved taxol production by combination of inducing factors in suspension cell culture of Taxus baccata . Cell Biol Int 2006; 30: 262-269
    CrossrefPubMedGoogle Scholar
  • 36 Asghari G, Mostajeran A, Sadeghi H, Nakhai A. Effect of salicylic acid and silver nitrate on taxol production in Taxus baccata . J Med Plants 2012; 11: 74-82
    PubMedGoogle Scholar
  • 37 Weathers PJ, Towler MJ, Xu J. Bench to batch: advances in plant cell culture for producing useful products. Appl Microbiol Biotechnol 2010; 85: 1339-1351
    CrossrefPubMedGoogle Scholar
  • 38 Malik S, Cusidó RM, Mirjalili MH, Moyano E, Palazón J, Bonfill M. Production of the anticancer drug taxol in Taxus baccata suspension cultures: a review. Process Biochem 2011; 46: 23-34
    CrossrefPubMedGoogle Scholar
  • 39 Expósito O, Bonfill M, Onrubia M, Jané A, Moyano E, Cusidó RM, Palazón J, Piñol MT. Effect of taxol feeding on taxol and related taxane production in Taxus baccata suspension cultures. N Biotechnol 2009; 25: 252-259
    CrossrefPubMedGoogle Scholar
  • 40 Qinghaosu Antimalaria Coordinating Research Group. Antimalaria studies on Qinghaosu. Chin Med J (Engl) 1979; 92: 811-816
    PubMedGoogle Scholar
  • 41 Ge H. Zhou Hou Bei Ji Fang. Tianjin, China: Tianjin Science and Technology Press; 2000
    Google Scholar
  • 42 Covello PS. Making artemisinin. Phytochemistry 2008; 69: 2881-2885
    CrossrefPubMedGoogle Scholar
  • 43 Westfall PJ, Pitera DJ, Lenihan JR, Eng D, Woolard FX, Regentin R, Horning T, Tsuruta H, Melis DJ, Owens A, Fickes S, Diola D, Benjamin KR, Keasling JD, Leavell MD, McPhee DJ, Renninger NS, Newman JD, Paddon CJ. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc Natl Acad Sci U S A 2012; 109: E111-E118
    CrossrefPubMedGoogle Scholar
  • 44 Martin VJJ, Pitera DJ, Withers ST, Newman JD, Keasling JD. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol 2003; 21: 796-802
    CrossrefPubMedGoogle Scholar
  • 45 Turconi J, Griolet F, Guevel R, Oddon G, Villa R, Geatti A, Hvala M, Rossen K, Göller R, Burgard A. Semisynthetic artemisinin, the chemical path to industrial production. Org Process Res Dev 2014; 18: 417-422
    CrossrefPubMedGoogle Scholar
  • 46 PATH. Sanofi and PATH announce the launch of large-scale production of semisynthetic artemisinin against malaria; 2013. Available at: http://www.path.org/news/press-room/422/ Accessed May 17, 2018
    PubMedGoogle Scholar
  • 47 Bailey JE. Toward a science of metabolic engineering. Science 1991; 252: 1668-1675
    CrossrefPubMedGoogle Scholar
  • 48 Staniek A, Bouwmeester H, Fraser PD, Kayser O, Martens S, Tissier A, van der Krol S, Wessjohann L, Warzecha H. Natural products – modifying metabolite pathways in plants. Biotechnol J 2013; 8: 1159-1171
    CrossrefPubMedGoogle Scholar
  • 49 OʼConnor SE. Engineering of secondary metabolism. Annu Rev Genet 2015; 49: 71-94
    CrossrefPubMedGoogle Scholar
  • 50 Funahashi A, Matsuoka Y, Jouraku A, Morohashi M, Kikuchi N, Kitano H. CellDesigner 3.5: a versatile modeling tool for biochemical networks. Proc IEEE 2008; 96: 1254-1265
    CrossrefPubMedGoogle Scholar
  • 51 Dasika MS, Maranas CD. OptCircuit: an optimization based method for computational design of genetic circuits. BMC Syst Biol 2008; 2: 24
    CrossrefPubMedGoogle Scholar
  • 52 Dai Z, Liu Y, Zhang X, Shi M, Wang B, Wang D, Huang L, Zhang X. Metabolic engineering of Saccharomyces cerevisiae for production of ginsenosides. Metab Eng 2013; 20: 146-156
    CrossrefPubMedGoogle Scholar
  • 53 Liu W, Stewart CN. Plant synthetic biology. Trends Plant Sci 2015; 20: 309-317
    CrossrefPubMedGoogle Scholar
  • 54 Toya Y, Shimizu H. Flux analysis and metabolomics for systematic metabolic engineering of microorganisms. Biotechnol Adv 2013; 31: 818-826
    CrossrefPubMedGoogle Scholar
  • 55 Dromms R, Styczynski M. Systematic applications of metabolomics in metabolic engineering. Metabolites 2012; 2: 1090-1122
    CrossrefPubMedGoogle Scholar
  • 56 de la Parra J, Quave CL. Ethnophytotechnology: harnessing the power of ethnobotany with biotechnology. Trends Biotechnol 2017; 35: 802-806
    CrossrefPubMedGoogle Scholar
  • 57 Pharmacompass. Natural product selling and pricing list. Available at: https://www.pharmacompass.com Accessed May 17, 2018
    PubMedGoogle Scholar
  • 58 Lim CG, Fowler ZL, Hueller T, Schaffer S, Koffas MAG. High-yield resveratrol production in engineered Escherichia coli . Appl Environ Microbiol 2011; 77: 3451-3460
    CrossrefPubMedGoogle Scholar
  • 59 Fulzele DP, Heble MR. Large-scale cultivation of Catharanthus roseus cells: production of ajamalicine in a 20-l airlift bioreactor. J Biotechnol 1994; 35: 1-7
    CrossrefPubMedGoogle Scholar
  • 60 Ramachandra Rao S, Ravishankar GA. Plant cell cultures: chemical factories of secondary metabolites. Biotechnol Adv 2002; 20: 101-153
    CrossrefPubMedGoogle Scholar
  • 61 Ravishankar GA, Ramachandra Rao S. Biotechnological production of phyto-pharmaceuticals. J Biochem Mol Biol Biophys 2000; 4: 73-102
    PubMedGoogle Scholar
  • 62 Brochado AR, Matos C, Møller BL, Hansen J, Mortensen UH, Patil KR. Improved vanillin production in bakerʼs yeast through in silico design. Microb Cell Fact 2010; 9: 84
    CrossrefPubMedGoogle Scholar
  • 63 Koopman F, Beekwilder J, Crimi B, van Houwelingen A, Hall RD, Bosch D, van Maris AJA, Pronk JT, Daran JM. De novo production of the flavonoid naringenin in engineered Saccharomyces cerevisiae . Microb Cell Fact 2012; 11: 155
    CrossrefPubMedGoogle Scholar
  • 64 Katz M, Durhuus T, Smits HP, Förster J. Production of metabolites. Patent WO2011147818; 2011.
    PubMedGoogle Scholar
  • 65 Paddon CJ, Westfall PJ, Pitera DJ, Benjamin K, Fisher K, McPhee D, Leavell MD, Tai A, Main A, Eng D, Polichuk DR, Teoh KH, Reed DW, Treynor T, Lenihan J, Jiang H, Fleck M, Bajad S, Dang G, Dengrove D, Diola D, Dorin G, Ellens KW, Fickes S, Galazzo J, Gaucher SP, Geistlinger T, Henry R, Hepp M, Horning T, Iqbal T, Kizer L, Lieu B, Melis D, Moss N, Regentin R, Secrest S, Tsuruta H, Vazquez R, Westblade LF, Xu L, Yu M, Zhang Y, Zhao L, Lievense J, Covello PS, Keasling JD, Reiling KK, Renninger NS, Newman JD. High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 2013; 496: 528-532
    CrossrefPubMedGoogle Scholar
  • 66 Thodey K, Galanie S, Smolke CD. A microbial biomanufacturing platform for natural and semisynthetic opioids. Nat Chem Biol 2014; 10: 837-844
    CrossrefPubMedGoogle Scholar